{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T14:58:06Z","timestamp":1771858686139,"version":"3.50.1"},"reference-count":79,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1657,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1111\/j.1524-4733.2008.00404.x","type":"journal-article","created":{"date-parts":[[2008,7,30]],"date-time":"2008-07-30T13:38:18Z","timestamp":1217425098000},"page":"55-64","source":"Crossref","is-referenced-by-count":130,"title":["The Burden of Migraine in the United States: Current and Emerging Perspectives on Disease Management and Economic Analysis"],"prefix":"10.1016","volume":"12","author":[{"given":"Elisabeth","family":"Hazard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Munakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo E.","family":"Bigal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia F.T.","family":"Rupnow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard B.","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1524-4733.2008.00404.x_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1468-2982.2005.00988.x","article-title":"Patterns of medical diagnosis and treatment of migraine and probable migraine in a health plan","volume":"26","author":"Bigal","year":"2006","journal-title":"Cephalalgia"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib20","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jclinepi.2004.01.014","article-title":"Pharmacy and medical claims data identified migraine sufferers with high specificity but modest sensitivity","volume":"57","author":"Kolodner","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib30","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1212\/01.WNL.0000142044.22226.54","article-title":"Prevalence and impact of migraine and probable migraine in a health plan","volume":"63","author":"Patel","year":"2004","journal-title":"Neurology"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1468-2982.2007.01288.x","article-title":"The global burden of headache: a documentation of headache prevalence and disability worldwide","volume":"27","author":"Stovner","year":"2007","journal-title":"Cephalalgia"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib50","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1001\/jama.290.18.2443","article-title":"Lost productive time and cost because of common pain conditions in the US workforce","volume":"290","author":"Stewart","year":"2003","journal-title":"JAMA"},{"issue":"Suppl.1","key":"10.1111\/j.1524-4733.2008.00404.x_bib60","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2165\/00019053-199700111-00003","article-title":"Burden of migraine. A review of its socioeconomic impact","volume":"11","author":"Solomon","year":"1997","journal-title":"Pharmacoeconomics"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib70","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archinte.159.8.813","article-title":"Burden of migraine in the United States: disability and economic costs","volume":"159","author":"Hu","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib80","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/jama.291.4.493","article-title":"Is migraine a progressive brain disease?","volume":"291","author":"Lipton","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib90","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3959(03)00293-8","article-title":"Factors associated with the onset and remission of chronic daily headache in a population-based study","volume":"106","author":"Scher","year":"2003","journal-title":"Pain"},{"issue":"6Suppl.4","key":"10.1111\/j.1524-4733.2008.00404.x_bib100","first-page":"S24","article-title":"Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration","volume":"44","author":"Stewart","year":"1994","journal-title":"Neurology"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib110","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0140-6736(92)90511-Z","article-title":"Cost of sumatriptan","volume":"340","author":"Feczko","year":"1992","journal-title":"Lancet"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib120","first-page":"1037","article-title":"A literature review comparing the economic, clinical, and humanistic attributes of dihydroergotamine and sumatriptan","volume":"16","author":"Kozma","year":"1994","journal-title":"Clin Ther"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib130","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1212\/WNL.53.7.1468","article-title":"Increasing incidence of medically recognized migraine headache in a United States population","volume":"53","author":"Rozen","year":"1999","journal-title":"Neurology"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib140","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1046\/j.1526-4610.2000.00031.x","article-title":"Incidence of medically recognized migraine: a 1989\u20131990 study in Olmsted County, Minnesota","volume":"40","author":"Rozen","year":"2000","journal-title":"Headache"},{"issue":"Suppl.2","key":"10.1111\/j.1524-4733.2008.00404.x_bib150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000119527","article-title":"The economic and social impact of migraine","volume":"34","author":"Stewart","year":"1994","journal-title":"Eur Neurol"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib160","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1526-4610.1994.hed3406319.x","article-title":"An update on the epidemiology of migraine","volume":"34","author":"Lipton","year":"1994","journal-title":"Headache"},{"issue":"Suppl.1","key":"10.1111\/j.1524-4733.2008.00404.x_bib170","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1526-4610.2005.4501001.x","article-title":"Migraine: epidemiology, impact, and risk factors for progression","volume":"45","author":"Lipton","year":"2005","journal-title":"Headache"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib180","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1001\/jama.1989.03420150061038","article-title":"An epidemiologic study of headache among adolescents and young adults","volume":"261","author":"Linet","year":"1989","journal-title":"JAMA"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib190","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.1992.03480010072027","article-title":"Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors","volume":"267","author":"Stewart","year":"1992","journal-title":"JAMA"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib200","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1526-4610.2001.041007646.x","article-title":"Prevalence and burden of migraine in the United States: data from the American Migraine Study II","volume":"41","author":"Lipton","year":"2001","journal-title":"Headache"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib210","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1526-4610.2006.00631.x","article-title":"Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study","volume":"47","author":"Diamond","year":"2007","journal-title":"Headache"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib220","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1212\/WNL.58.6.885","article-title":"Migraine in the United States: epidemiology and patterns of health care use","volume":"58","author":"Lipton","year":"2002","journal-title":"Neurology"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib230","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","article-title":"Migraine prevalence, disease burden, and the need for preventive therapy","volume":"68","author":"Lipton","year":"2007","journal-title":"Neurology"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib240","first-page":"45","article-title":"Advances in migraine management: implications for managed care organizations","volume":"13","author":"Dodick","year":"2004","journal-title":"Manag Care"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib250","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/aje\/kwi139","article-title":"Incidence of primary headache: a Danish epidemiologic follow-up study","volume":"161","author":"Lyngberg","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib260","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1046\/j.1468-2982.1997.1704488.x","article-title":"A 40-year follow-up of school children with migraine","volume":"17","author":"Bille","year":"1997","journal-title":"Cephalalgia"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib270","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1526-4610.1998.3802087.x","article-title":"Medical consultation for migraine: results from the American Migraine Study","volume":"38","author":"Lipton","year":"1998","journal-title":"Headache"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib280","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1526-4610.1992.hed3205223.x","article-title":"Medication use and disability among migraineurs: a national probability sample survey","volume":"32","author":"Celentano","year":"1992","journal-title":"Headache"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib290","series-title":"Headache-Problems in Diagnosis and Management","article-title":"Illness behavior and headache, and the sociology of consultations for headache","author":"Fitzpatrick","year":"1988"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib300","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1023\/A:1026179517081","article-title":"Usefulness of the SF-8 Health Survey for comparing the impact of migraine and other conditions","volume":"12","author":"Turner-Bowker","year":"2003","journal-title":"Qual Life Res"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib310","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1212\/WNL.55.5.629","article-title":"Migraine, quality of life, and depression: a population-based case-control study","volume":"55","author":"Lipton","year":"2000","journal-title":"Neurology"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib320","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.clinthera.2007.05.008","article-title":"The cycle of migraine: patients' quality of life during and between migraine attacks","volume":"29","author":"Freitag","year":"2007","journal-title":"Clin Ther"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib330","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1526-4610.1994.hed3406337.x","article-title":"Measuring the functional status and well-being of patients with migraine headache","volume":"34","author":"Osterhaus","year":"1994","journal-title":"Headache"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib340","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1526-4610.2004.446004.x","article-title":"The medical costs of migraine and comorbid anxiety and depression","volume":"44","author":"Pesa","year":"2004","journal-title":"Headache"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib350","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3111\/200306043053","article-title":"Estimating the cost of an emergency room visit for migraine attack","volume":"6","author":"Barron","year":"2003","journal-title":"J Med Econ"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib360","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1526-4610.2002.04262.x","article-title":"The economic impact of migraine: an analysis of direct and indirect costs","volume":"42","author":"Edmeads","year":"2002","journal-title":"Headache"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib370","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1525-1497.2004.30021.x","article-title":"The medical care utilization and costs associated with migraine headache","volume":"19","author":"Elston","year":"2004","journal-title":"J Gen Intern Med"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib380","doi-asserted-by":"crossref","first-page":"137","DOI":"10.18553\/jmcp.2005.11.2.137","article-title":"Costs and utilization of triptan users who receive drug prophylaxis for migraine versus triptan users who do not receive drug prophylaxis","volume":"11","author":"Etemad","year":"2005","journal-title":"J Manag Care Pharm"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib390","doi-asserted-by":"crossref","first-page":"A85","DOI":"10.1016\/S1098-3015(10)64567-6","article-title":"Direct cost burden of migraine among members of US employers","volume":"9","author":"Hawkins","year":"2006","journal-title":"Value Health"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib400","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1046\/j.1526-4610.2003.03067.x","article-title":"Health care utilization in patients with migraine: demographics and patterns of care in the ambulatory setting","volume":"43","author":"Gibbs","year":"2003","journal-title":"Headache"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib410","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.wco.0000169750.52406.a2","article-title":"Comorbidity of migraine","volume":"18","author":"Scher","year":"2005","journal-title":"Curr Opin Neurol"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib420","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1177\/106002809402800518","article-title":"Healthcare resource use and costs associated with migraine in a managed healthcare setting","volume":"28","author":"Clouse","year":"1994","journal-title":"Ann Pharmacother"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib430","first-page":"313","article-title":"The family impact and costs of migraine","volume":"10","author":"Stang","year":"2004","journal-title":"Am J Manag Care"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib440","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1468-2982.1996.1604231.x","article-title":"Work-related disability: results from the American migraine study","volume":"16","author":"Stewart","year":"1996","journal-title":"Cephalalgia"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib450","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1212\/WNL.50.6.1741","article-title":"Migraine and reduced work performance: a population-based diary study","volume":"50","author":"Von","year":"1998","journal-title":"Neurology"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib460","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00043764-199704000-00009","article-title":"Lost workdays and decreased work effectiveness associated with headache in the workplace","volume":"39","author":"Schwartz","year":"1997","journal-title":"J Occup Environ Med"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib470","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00019053-200119020-00006","article-title":"The multinational impact of migraine symptoms on healthcare utilisation and work loss","volume":"19","author":"Gerth","year":"2001","journal-title":"Pharmacoeconomics"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib480","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/01.jom.0000121151.40413.bd","article-title":"Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers","volume":"46","author":"Goetzel","year":"2004","journal-title":"J Occup Environ Med"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib490","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/JOM.0b013e31803b9510","article-title":"Indirect cost burden of migraine in the United States","volume":"49","author":"Hawkins","year":"2007","journal-title":"J Occup Environ Med"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib500","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1526-4610.1985.hed2504214.x","article-title":"The efficacy and cost-effectiveness of minimal-therapist-contact, non-drug treatments of chronic migraine and tension headache","volume":"25","author":"Blanchard","year":"1985","journal-title":"Headache"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib510","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1526-4610.1989.hed2906352.x","article-title":"Cognitive-behavioral therapy for migraine headaches: a minimal-therapist-contact approach versus a clinic-based approach","volume":"29","author":"Richardson","year":"1989","journal-title":"Headache"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib520","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00019053-199202010-00008","article-title":"Healthcare resource and lost labour costs of migraine headache in the US","volume":"2","author":"Osterhaus","year":"1992","journal-title":"Pharmacoeconomics"},{"issue":"Suppl.4","key":"10.1111\/j.1524-4733.2008.00404.x_bib530","first-page":"S56","article-title":"The economic cost of migraine. Present state of knowledge","volume":"44","author":"de Lissovoy","year":"1994","journal-title":"Neurology"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib540","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00019053-199406030-00005","article-title":"The burden of migraine. A review of cost to society","volume":"6","author":"Lipton","year":"1994","journal-title":"Pharmacoeconomics"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib550","first-page":"117","article-title":"Cost-effectiveness of sumatriptan in a managed care population","volume":"3","author":"Legg","year":"1997","journal-title":"Am J Manag Care"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib560","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1592\/phco.20.17.1356.34890","article-title":"Cost-benefit analysis of sumatriptan tablets versus usual therapy for treatment of migraine","volume":"20","author":"Biddle","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib570","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2165\/00003495-199855060-00020","article-title":"Sumatriptan. An updated review of its use in migraine","volume":"55","author":"Perry","year":"1998","journal-title":"Drugs"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib580","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1185\/030079904125003403","article-title":"Cost effectiveness of oral triptan therapy: a trans-national comparison based on a meta-analysis of randomised controlled trials","volume":"20","author":"Belsey","year":"2004","journal-title":"Curr Med Res Opin"},{"issue":"Suppl.3","key":"10.1111\/j.1524-4733.2008.00404.x_bib590","first-page":"S94","article-title":"Almotriptan versus sumatriptan in migraine treatment: direct medical costs of managing adverse chest symptoms","volume":"8","author":"Mannix","year":"2002","journal-title":"Am J Manag Care"},{"issue":"Suppl.3","key":"10.1111\/j.1524-4733.2008.00404.x_bib600","first-page":"S80","article-title":"Economic comparison of oral triptans for management of acute migraine: implications for managed care","volume":"8","author":"Reeder","year":"2002","journal-title":"Am J Manag Care"},{"issue":"Suppl.3","key":"10.1111\/j.1524-4733.2008.00404.x_bib610","first-page":"S102","article-title":"Cost savings in migraine associated with less chest pain on new triptan therapy","volume":"8","author":"Wang","year":"2002","journal-title":"Am J Manag Care"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib620","doi-asserted-by":"crossref","first-page":"259","DOI":"10.18553\/jmcp.2004.10.3.259","article-title":"A comparison of the cost-effectiveness of almotriptan and sumatriptan in the treatment of acute migraine using a composite efficacy\/tolerability end point","volume":"10","author":"Williams","year":"2004","journal-title":"J Manag Care Pharm"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib630","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1016\/S0149-2918(03)80344-2","article-title":"Cost-effectiveness of almotriptan and rizatriptan in the treatment of acute migraine","volume":"25","author":"Williams","year":"2003","journal-title":"Clin Ther"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib640","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1524-4733.2005.00056.x","article-title":"An economic evaluation of triptan products for migraine","volume":"8","author":"Perfetto","year":"2005","journal-title":"Value Health"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib650","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2165\/00023210-200519070-00005","article-title":"Cost-effectiveness analysis of rizatriptan and sumatriptan versus Cafergot in the acute treatment of migraine","volume":"19","author":"Zhang","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib660","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1212\/WNL.59.7.1011","article-title":"Features of medication overuse headache following overuse of different acute headache drugs","volume":"59","author":"Limmroth","year":"2002","journal-title":"Neurology"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib670","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/ajhp\/56.21.2206","article-title":"HMO direct costs and health care resources use after implementation of a monthly limit on sumatriptan","volume":"56","author":"Goldfarb","year":"1999","journal-title":"Am J Health Syst Pharm"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib680","doi-asserted-by":"crossref","first-page":"335","DOI":"10.18553\/jmcp.2003.9.4.335","article-title":"Evaluation of a monthly coverage maximum (drug-specific quantity limit) on the 5-HT1 agonists (triptans) and dihydroergotamine nasal spray","volume":"9","author":"Hoffman","year":"2003","journal-title":"J Manag Care Pharm"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib690","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1526-4610.1995.hed3508479.x","article-title":"Cost considerations in headache treatment. Part 1: prophylactic migraine treatment","volume":"35","author":"Adelman","year":"1995","journal-title":"Headache"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib700","series-title":"Treatment of Primary Headache: Preventive Treatment of Migraine. Standards of Care for Headache Diagnosis and Treatment","author":"Kaniecki","year":"2004"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib710","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01.wco.0000169747.67653.f3","article-title":"Preventive treatment of headaches","volume":"18","author":"Silberstein","year":"2005","journal-title":"Curr Opin Neurol"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib720","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1046\/j.1526-4610.2002.02227.x","article-title":"Cost-effectiveness of antiepileptic drugs in migraine prophylaxis","volume":"42","author":"Adelman","year":"2002","journal-title":"Headache"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib730","first-page":"31","article-title":"Cost effectiveness of topiramate in the prevention of migraines in the United States: an update","volume":"19","author":"Brown","year":"2006","journal-title":"Manag Care Interface"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib740","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1468-2982.2004.00857_1.x","article-title":"Invited lectures","volume":"24","year":"2004","journal-title":"Cephalalgia"},{"issue":"Suppl.1","key":"10.1111\/j.1524-4733.2008.00404.x_bib750","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1111\/j.1526-4610.2005.4501002.x","article-title":"General principles of migraine management: the changing role of prevention","volume":"45","author":"Loder","year":"2005","journal-title":"Headache"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib760","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/jnnp.69.4.507","article-title":"Long term decline of P100 amplitude in migraine with aura","volume":"69","author":"Khalil","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib770","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jama.291.4.427","article-title":"Migraine as a risk factor for subclinical brain lesions","volume":"291","author":"Kruit","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib780","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/NRL.0b013e3180691208","article-title":"Migraine with aura is a risk factor for cardiovascular and cerebrovascular disease: a critically appraised topic","volume":"13","author":"Wingerchuk","year":"2007","journal-title":"Neurologist"},{"key":"10.1111\/j.1524-4733.2008.00404.x_bib790","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1468-2982.2007.01407.x","article-title":"Migraine and ischaemic heart disease and stroke: potential mechanisms and treatment implications","volume":"27","author":"Tietjen","year":"2007","journal-title":"Cephalalgia"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301510606730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301510606730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T21:07:38Z","timestamp":1709154458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301510606730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S1098301510606730"],"URL":"https:\/\/doi.org\/10.1111\/j.1524-4733.2008.00404.x","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}